image
Consumer Defensive - Packaged Foods - NASDAQ - US
$ 13.83
0.145 %
$ 173 M
Market Cap
43.22
P/E
1. INTRINSIC VALUE

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.[ Read More ]

The intrinsic value of one LFVN stock under the base case scenario is HIDDEN Compared to the current market price of 13.8 USD, LifeVantage Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart LFVN

image
FINANCIALS
200 M REVENUE
-6.20%
4.33 M OPERATING INCOME
1.71%
2.94 M NET INCOME
15.63%
12.2 M OPERATING CASH FLOW
78.63%
-2.24 M INVESTING CASH FLOW
26.61%
-14.4 M FINANCING CASH FLOW
-511.67%
47.2 M REVENUE
-3.51%
2.57 M OPERATING INCOME
-11.68%
1.83 M NET INCOME
39.92%
-583 K OPERATING CASH FLOW
-22.58%
-345 K INVESTING CASH FLOW
-24.10%
-1.83 M FINANCING CASH FLOW
33.31%
Balance Sheet Decomposition LifeVantage Corporation
image
Current Assets 37.6 M
Cash & Short-Term Investments 16.9 M
Receivables 3.26 M
Other Current Assets 17.5 M
Non-Current Assets 22.7 M
Long-Term Investments 0
PP&E 17.4 M
Other Non-Current Assets 5.27 M
Current Liabilities 22.3 M
Accounts Payable 5.85 M
Short-Term Debt 3.62 M
Other Current Liabilities 12.8 M
Non-Current Liabilities 12 M
Long-Term Debt 11.8 M
Other Non-Current Liabilities 198 K
EFFICIENCY
Earnings Waterfall LifeVantage Corporation
image
Revenue 200 M
Cost Of Revenue 41.4 M
Gross Profit 159 M
Operating Expenses 154 M
Operating Income 4.33 M
Other Expenses 1.4 M
Net Income 2.94 M
RATIOS
79.30% GROSS MARGIN
79.30%
2.16% OPERATING MARGIN
2.16%
1.47% NET MARGIN
1.47%
11.30% ROE
11.30%
4.87% ROA
4.87%
10.52% ROIC
10.52%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis LifeVantage Corporation
image
Net Income 2.94 M
Depreciation & Amortization 3.58 M
Capital Expenditures -2.24 M
Stock-Based Compensation 3.28 M
Change in Working Capital 2.38 M
Others 2.14 M
Free Cash Flow 9.95 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets LifeVantage Corporation
image
LFVN has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.34% DIVIDEND YIELD
0.04 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership LifeVantage Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
33 K USD 1
Bought
10.8 K USD 2
0-3 MONTHS
3.61 K USD 1
3-6 MONTHS
3.14 K USD 1
6-9 MONTHS
50.5 K USD 2
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Sep 17, 2024
Bought 61.4 USD
Lewis Darwin
Director
+ 6
10.2342 USD
2 months ago
Sep 17, 2024
Bought 3.56 K USD
Lewis Darwin
Director
+ 345
10.3101 USD
2 months ago
Sep 03, 2024
Bought 4.44 K USD
Mauro Garry Paul
Director
+ 600
7.405 USD
2 months ago
Sep 03, 2024
Bought 2.31 K USD
Mauro Garry Paul
Director
+ 312
7.405 USD
2 months ago
Sep 03, 2024
Bought 474 USD
Mauro Garry Paul
Director
+ 64
7.405 USD
5 months ago
Jun 14, 2024
Bought 103 USD
Lewis Darwin
Director
+ 14
7.3592 USD
5 months ago
Jun 14, 2024
Bought 3.51 K USD
Lewis Darwin
Director
+ 475
7.3828 USD
8 months ago
Mar 15, 2024
Bought 62.4 USD
Lewis Darwin
Director
+ 9
6.9356 USD
8 months ago
Mar 15, 2024
Bought 3.08 K USD
Lewis Darwin
Director
+ 440
6.9999 USD
9 months ago
Feb 02, 2024
Bought 917 USD
Mauro Garry Paul
Director
+ 162
5.66 USD
9 months ago
Feb 02, 2024
Bought 211 USD
Mauro Garry Paul
Director
+ 37
5.71 USD
11 months ago
Dec 15, 2023
Bought 34.4 USD
Lewis Darwin
Director
+ 5
6.8767 USD
11 months ago
Dec 15, 2023
Bought 3.08 K USD
Lewis Darwin
Director
+ 455
6.7762 USD
11 months ago
Nov 20, 2023
Sell 33 K USD
BEINDORFF MICHAEL A
Director
- 5500
6 USD
1 year ago
Nov 16, 2023
Bought 23.6 K USD
Mauro Garry Paul
Director
+ 4970
4.7473 USD
1 year ago
Nov 15, 2023
Bought 9.41 K USD
Mauro Garry Paul
Director
+ 2024
4.6498 USD
1 year ago
Nov 16, 2023
Bought 10.7 K USD
Mauro Garry Paul
Director
+ 2262
4.7473 USD
1 year ago
Nov 16, 2023
Bought 2.47 K USD
Mauro Garry Paul
Director
+ 520
4.7473 USD
1 year ago
Sep 22, 2023
Bought 28.6 K USD
Lewis Darwin
Director
+ 4124
6.9427 USD
1 year ago
Sep 05, 2023
Bought 3.24 K USD
Mauro Garry Paul
Director
+ 425
7.632 USD
1 year ago
Sep 05, 2023
Bought 840 USD
Mauro Garry Paul
Director
+ 110
7.632 USD
1 year ago
Sep 05, 2023
Bought 191 USD
Mauro Garry Paul
Director
+ 25
7.632 USD
1 year ago
Aug 25, 2023
Bought 27.2 K USD
Dayton Judd
+ 5490
4.952 USD
1 year ago
Aug 24, 2023
Bought 34.8 K USD
Dayton Judd
+ 7226
4.821 USD
1 year ago
Aug 23, 2023
Bought 18 K USD
Dayton Judd
+ 3788
4.7647 USD
1 year ago
Aug 11, 2023
Bought 101 K USD
Radoff Bradley Louis
+ 20000
5.0666 USD
1 year ago
May 25, 2023
Bought 8.42 K USD
BEINDORFF MICHAEL A
Director
+ 2000
4.21 USD
1 year ago
May 24, 2023
Bought 13.2 K USD
BEINDORFF MICHAEL A
Director
+ 3000
4.4 USD
1 year ago
May 12, 2023
Bought 631 USD
Mauro Garry Paul
Director
+ 150
4.2074 USD
1 year ago
May 10, 2023
Bought 14.9 K USD
Mauro Garry Paul
Director
+ 3650
4.0799 USD
1 year ago
May 10, 2023
Bought 694 USD
Mauro Garry Paul
Director
+ 170
4.0799 USD
1 year ago
May 09, 2023
Bought 3.88 K USD
Lewis Darwin
Director
+ 1000
3.8784 USD
2 years ago
Feb 07, 2022
Bought 34.9 K USD
BEINDORFF MICHAEL A
Director
+ 7193
4.85 USD
2 years ago
Dec 07, 2021
Sell 13.3 K USD
BEINDORFF MICHAEL A
Director
- 2000
6.63 USD
2 years ago
Dec 08, 2021
Sell 34 K USD
BEINDORFF MICHAEL A
Director
- 5143
6.62 USD
4 years ago
Sep 16, 2020
Sell 17 K USD
Rose Justin
Chief Sales &Marketing Officer
- 1250
13.58 USD
4 years ago
Aug 19, 2020
Sell 16.6 K USD
Rose Justin
Chief Sales Officer
- 1250
13.26 USD
4 years ago
Aug 19, 2020
Sell 59.1 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
13.13 USD
4 years ago
Jul 15, 2020
Sell 16.9 K USD
Rose Justin
Chief Sales Officer
- 1250
13.55 USD
4 years ago
Jul 15, 2020
Sell 60.8 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
13.5 USD
4 years ago
Jun 17, 2020
Sell 64.8 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
14.41 USD
4 years ago
Jun 17, 2020
Sell 18.2 K USD
Rose Justin
Chief Sales Officer
- 1250
14.6 USD
4 years ago
May 20, 2020
Sell 17.5 K USD
Rose Justin
Chief Sales Officer
- 1250
14 USD
4 years ago
May 20, 2020
Sell 63 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
14.01 USD
4 years ago
Apr 15, 2020
Sell 30 K USD
Rose Justin
Chief Sales Officer
- 2500
12 USD
4 years ago
Apr 15, 2020
Sell 51.1 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
11.36 USD
4 years ago
Mar 18, 2020
Sell 37.4 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
8.3 USD
4 years ago
Feb 19, 2020
Sell 19.6 K USD
Rose Justin
Chief Sales Officer
- 1250
15.64 USD
4 years ago
Feb 19, 2020
Sell 69.8 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
15.52 USD
4 years ago
Jan 15, 2020
Sell 69.7 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
15.48 USD
4 years ago
Dec 18, 2019
Sell 70.6 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
15.68 USD
4 years ago
Nov 20, 2019
Sell 63.6 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
14.13 USD
5 years ago
Nov 30, 2018
Bought 19.8 K USD
Greer Raymond B
Director
+ 1500
13.22 USD
5 years ago
Nov 26, 2018
Bought 13.7 K USD
Mauro Garry Paul
Director
+ 1150
11.94 USD
7. News
LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript LifeVantage Corporation (NASDAQ:LFVN ) Q1 2025 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Douglas Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by. seekingalpha.com - 2 weeks ago
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025 SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. globenewswire.com - 2 weeks ago
LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. globenewswire.com - 2 weeks ago
LifeVantage to Announce First Quarter Fiscal Year 2025 Results on October 29, 2024 SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. globenewswire.com - 1 month ago
LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger Hormones and Reduce Cravings, Supporting Sustainable Weight and Visceral Fat Loss While Maintaining Muscle ‡Ω globenewswire.com - 1 month ago
LifeVantage Announces Update to Evolve Compensation Plan with New Sharing Bonus Enhancements simplify the path to success for independent Consultants Enhancements simplify the path to success for independent Consultants globenewswire.com - 1 month ago
LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference SALT LAKE CITY, Sept. 04, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 26th Annual Global Investment Conference, to be held September 9-11, 2024 in New York, NY. globenewswire.com - 2 months ago
LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript LifeVantage Corporation (NASDAQ:LFVN ) Q4 2024 Earnings Conference Call August 28, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & CEO Carl Aure - CFO Conference Call Participants Douglas Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by. seekingalpha.com - 2 months ago
LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid September 17, 2024 to all stockholders of record at the close of business on September 9, 2024. globenewswire.com - 2 months ago
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2024 SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2024. globenewswire.com - 2 months ago
LifeVantage Welcomes Rajendran Anbalagan to the Board of Directors; Thanks Erin Brockovich for Her Years of Service SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company's Board of Directors effective today. The appointment comes after the Board conducted a comprehensive search to identify a candidate with transformational digital skills and identified Mr. Anbalagan as an exceptional choice. globenewswire.com - 2 months ago
LifeVantage Concludes Rise Retreat in Park City with Exclusive Preview of New Innovative Weight Management Solution Event highlighted new weight management products while fostering strategic collaboration and recognition among Consultants Event highlighted new weight management products while fostering strategic collaboration and recognition among Consultants globenewswire.com - 2 months ago
8. Profile Summary

LifeVantage Corporation LFVN

image
COUNTRY US
INDUSTRY Packaged Foods
MARKET CAP $ 173 M
Dividend Yield 0.34%
Description LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
Contact 3300 North Triumph Boulevard, Lehi, UT, 84043 https://www.lifevantage.com
IPO Date April 7, 1994
Employees 222
Officers Ms. Julie Boyster Chief Marketing Officer Ms. Kristen Cunningham Chief Sales Officer Ms. Michelle Oborn-Virchow Chief People Officer Mr. Robert Harris Chief Digital Officer